Evidence map›Paper›PMID 40715522›Full record

ArticleScientific reports2025

Development and evaluation of a Cu(II) complex as nanosuspension for enhanced antitumor efficacy against glioblastoma cancer.

Marzieh Anjomshoa, Bagher Amirheidari, Alireza Kordjamshidi, Alireza Farsinejad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marzieh AnjomshoaDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical sciences, Haft-Bagh Highway, Kerman, 76169-13555, Iran. anjomshoa_1014@yahoo.com.
Bagher AmirheidariDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical sciences, Haft-Bagh Highway, Kerman, 76169-13555, Iran. baheidari@gmail.com.
Alireza KordjamshidiDepartment of Pharmacy, Eastern Mediterranean University, TRNC via Mersin 10, Gazimagusa, Turkey.
Alireza FarsinejadDepartment of Hematology and Medical Laboratory Sciences, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical application of the metal complexes with promising anticancer activity is limited due to their extremely poor water solubility. To circumvent this, approaches based on drug delivery systems are routinely examined. Herein, an aqueous nanosuspension of a Cu(II) complex, [Cu(

Indexed as

Antineoplastic AgentsCoordination ComplexesCopperGlioblastomaNanoparticlesApoptosisCell Line, TumorHumansParticle SizeSolubilityAntineoplastic AgentsCoordination ComplexesCopperAntimetastatic activityApoptosisCopper(II) complexDrug delivery systemsNanosuspensionReal-time PCR

Identifiers

PMID40715522
PMCPMC12297711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.